- Steinberg W, Tenner S. Acute pancreatitis. N Engl J Med 1994; 330:1198-210.
- Beger HG, Bittner R, Block S, Buchler M. Bacterial contamination of pancreatic necrosis. A prospective clinical study. Gastroenterology 1986;91:433-8.
- Reber HA. Acute pancreatitis: another piece of the puzzle? N Engl J Med 1991;325:423-5.
- Steer ML. Classification and pathogenesis of pancreatitis. Surg Clin North Am 1989;69:467-80.
- Steer ML. Frank Brooks memorial Lecture: the early intraacinar cell events which occur during acute pancreatitis. Pancreas 1998;17:31-7.
- Hietaranta AJ, Saluja AK, Bhagat L, Singh VP, Song AM, Steer ML. Relationship between NF-kappaB and trypsinogen activation in rat pancreas after supramaximal caerulein stimulation. Biochem Biophys Res Commun 2001;280:388-95.
- Whitcomb DC, Gorry MC, Preston RA, Furey W, Sossenheimer MI, Ulrich CD, et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 1996; 14: 141-5.
- Whitcomb DC. Early trypsinogen activation in acute pancreatitis. Gastroenterology 1999;116:770-2.
- Marshall JB. Acute pancreatitis. A review with an emphasis on new developments. Arch Intern Med 1993;153:1185-98.
- Itkonen O, Koivunen E, Hurme M, Alfthan H, Schröder T, Stenman UH. Time-resolved immunofluorometric assays for trypsinogen-1 and 2 in serum reveal preferential elevation of trypsinogen-2 in pancreatitis. J Lab Clin Med 1990;115:712-8.
- Kassell B, Kay J. Zymogens of proteolytic enzymes. Science 1973;180:1022-7.
- Sainio V, Puolakkainen P, Kemppainen E, Hedstrom J, Haapiainen R, Kivisaari L, et al. Serum trypsinogen-2 in the prediction of outcome in acute necrotizing pancreatitis. Scand J Gastroenterol 1996;31:818-24.
- Gudgeon AM, Heath DI, Hurley P, Jehanli A, Patel G, Wilson C, et al. Trypsinogen activation peptides assay in the early prediction of severity of acute pancreatitis. Lancet 1990;335:4-8.
- Tenner S, Femandez-del Castillo C, Warshaw A, Steinberg W, Hermon-Taylor J, Valenzuela JE, et al. Urinary trypsinogen activation peptide (TAP) predicts severity in patients with acute pancreatitis. Int J Pancreatol 1997;21:105-10.
- Neoptolemos JP, Kemppainen EA, Mayer JM, Fitzpatrick JM, Raraty MG, Slavin J, et al. Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study [In Process Citation]. Lancet 2000;355:1955-60.
- Pfützer RH, Barmada MM, Brunskill AP, Finch R, Hart PS, Neoptolemos J, et al. SPINK1/PSTI polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis. Gastroenterology 2000;119:615-23.
- Hedström J, Leinonen J, Sainio V, Stenman UH. Time-resolved immunofluorometric assay of trypsin-2 complexed with alpha 1-antitrypsin in serum. Clin Chem 1994;40:1761-5.
- Borgström A, Ohlsson K. Immunoreactive trypsin in serum and peritoneal fluid in acute pancreatitis. Hoppe Seylers Z Physiol Chem 1978;359:677-81.
- Bradley EL, 3rd. A clinically based classification system for acute pancreatitis. Summary of the international symposium on acute pancreatitis, Atlanta, GA, 11-13 September 1992. Arch Surg 1993;128:586-90.
- Hedström J, Haglund C, Kemppainen E, Leinimaa M, Leinonen J, Stenman UH. Time-resolved immunofluorometric assay of trypsin-1 complexed with alpha(1)-antitrypsin in serum: increased immunoreactivity in patients with biliary tract cancer. Clin Chem 1999;45:1768-73.
- Osman S, Turpeinen U, Itkonen O, Stenman UH. Optimization of a time-resolved immunofluorometric assay for tumorassociated trypsin inhibitor (TATI) using the streptavidin-biotin system. J Immunol Methods 1993;161:97-106.
- Hurley PR, Cook A, Jehanli A, Austen BM, Hermon-Taylor J. Development of radioimmunoassays for free tetra-L-aspartyl-L-lysine trypsinogen activation peptides (TAP). J Immunol Methods 1988;111:195-203.
- Appelros S, Thim L, Borgström A. Activation peptide of caiboxypeptidase B in serum and urine in acute pancreatitis. Gut 1998;42:97-102.
- Appelros S, Petersson U, Toh S, Johnson C, Borgström A. Activation peptide of caiboxypeptidase B and anionic trypsinogen as early predictors of the severity of acute pancreatitis. Br J Surg 2001;88:216-21.
- Müller CA, Appelros S, Uhl W, Büchler MW, Borgström A. Serum levels of procarboxypeptidase B and its activation peptide in patients with acute pancreatitis and non-pancreatic diseases. Gut 2002;51:229-35.
- Kimland M, Russick C, Marks WH, Borgström A. Immunoreactive anionic and cationic trypsin in human serum. Clin Chim Acta 1989;184:31-46.
- Borgström A, Ohlsson K. Studies on the turnover of endogenous cathodal trypsinogen in man. Eur J Clin Invest 1978;8:379-82.
- Hedström J, Sainio V, Kemppainen E, Puolakkainen P, Haapiainen R, Kivilaakso E, et al. Urine trypsinogen-2 as marker of acute pancreatitis. Clin Chem 1996;42:685-90.
- Petersson U, Appelros S, Borgström A. Different patterns in immunoreactive anionic and cationic trypsinogen in urine and serum in human acute pancreatitis. Int J Pancreatol 1999;25:165-70.
- Hedström J, Korvuo A, Kenkimaki P, Tikanoja S, Haapiainen R, Kivilaakso E, et al. Urinary trypsinogen-2 test strip for acute pancreatitis. Lancet 1996;347:729-30.
- Borgström A. The fate of intravenously injected trypsinogens in dogs. Scand J Gastroenterol 1981;16:281-7.
- Borgström A, Lassen A. Trypsin-alpha 1-protease inhibitor complexes in serum and clinical course of acute pancreatitis. Scand J Gastroenterol 1984;19:1119-22.
- Hedström J, Sainio V, Kemppainen E, Haapiainen R, Kivilaakso E, Schröder T, et al. Serum complex of trypsin 2 and alpha 1 antitrypsin as diagnostic and prognostic marker of acute pancreatitis: clinical study in consecutive patients. Br Med J 1996;313:333-7.
- Hartwig W, Jimenez RE, Werner J, Lewandrowski KB, Warshaw AL, Fernandez-del Castillo C. Interstitial trypsinogen release and its relevance to the transformation of mild into necrotizdng pancreatitis in rats. Gastroenterology 1999;117:717-25.
- Pezzilli R, Billi P, Plate L, Barakat B, Bongiovanni F, Miglioli M. Human pancreatic secretory trypsin inhibitor in the assessment of the severity of acute pancreatitis. A comparison with C-reactive protein. J Clin Gastroenterol 1994;19:112-7.
- Halila H, Huhtala ML, Schröder T, Kiviluoto T, Stenman UH. Pancreatic secretory trypsin inhibitor-like immunoreactivity in pancreatectomized patients. Clin Chim Acta 1985;153:209-16.
- Iovanna J, Orelle B, Keim V, Dagorn JC. Messenger RNA sequence and expression of rat pancreatitis-associated protein, a lectin-related protein overexpressed during acute experimental pancreatitis. J Biol Chem 1991;266:24664-9.
- Stenman UH. Tumor-associated trypsin inhibitor. Clin Chem 2002;48:1206-9.
- Ohmachi Y, Murata A, Matsuura N, Yasuda T, Monden M, Mori T, et al. Specific expression of the pancreatic-secretory-trypsin-inhibitor (PSTI) gene in hepatocellular carcinoma. Int J Cancer 1993;55:728-34.
- Lasson A, Borgström A, Ohlsson K. Elevated pancreatic secretory trypsin inhibitor levels during severe inflammatory disease, renal insufficiency, and after various surgical procedures. Scand J Gastroenterol 1986;21:1275-80.
- Ogawa M. Pancreatic secretory trypsin inhibitor as an acute phase reactant. Clin Biochem 1988;21:19-25.
- Puolakkainen P, Valtonen V, Paananen A, Schröder T. C-reactive protein (CRP) and serum phospholipase A2 in the assessment of the severity of acute pancreatitis. Gut 1987;28: 764-71.
- Guy O, Bartelt DC, Amic J, Colomb E, Figarella C. Activation peptide of human trypsinogen 2. FEBS Lett 1976;62:150-3.
- Guy O, Lombarde D, Bartelt DC, Amic J, Figarella C. Two human trypsinogens. Purification, molecular properties, and N-terminal sequences. Biochemistry 1978;17:1669-75.
- Simpson KW, Beechey-Newman N, Lamb CR, Smyth JB, Hughes G, Coombe K, et al. Cholecystokinin-8 induces edematous pancreatitis in dogs associated with short burst of trypsinogen activation. Dig Dis Sci 1995;40:2152-61.
- Ohlsson K. Interactions in vitro and in vivo between dog trypsin and dog plasma protease inhibitors. Scand J Clin Lab Invest 1971;28:220-3.
Sequential Changes in Pancreatic Markers in Acute Pancreatitis
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.